Print

Lonza Inc. Closes Ireland Site as U.S. Manufacturing Issues Causes Shortage of Ipsen (IPN.PA)'s Increlex  
5/1/2013 8:20:36 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Manufacturing disruptions at Lonza's Hopkinton, Massachusetts site are causing shortages of Ipsen Biopharmaceuticals’ growth failure treatment for children in both the US and EU, just as the company announces that it will shutter another manufacturing site in Ireland.

Help employers find you! Check out all the jobs and post your resume.

//-->